LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Basics of Compounding: Basics of Compounding with Organic Salts

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Abstract:  The purity and form of all ingredients used in compounding, especially of active pharmaceutical ingredients, must be known and considered during formulation. When a prescription is received, it is the responsibility of the pharmacist, and should be routine procedure, to correctly determine whether or not the salt or base/acid form of a drug is to be used as the basis for the dose. This is important information because the bulk substance, or active pharmaceutical ingredient, in a salt form is not 100% active drug. The purpose of the salt form is usually to enhance the solubility of the drug, but it may also enhance and change other attributes of the drug that make it easier to handle and manipulate for producing dosage forms. Resources for the purpose of determining this information include the United States Pharmacopeia, product package insert, and a call to the manufacturer or physician as appropriate. This article discusses compounding with salts and the factors that may affect a final compounded preparatio

Related Keywords: Loyd V. Allen Jr., PhD, RPh, organic salts, active drug, drug solubility, bulk drugs, United States Pharmacopeia, USP articldes, dosage forms

Related Categories: SUPPORT, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Basics of Compounding: Basics of Compounding with Organic Salts Allen Loyd V Jr Jul/Aug 2010 322-326 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W May/Jun 2016 202-206 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Allen Loyd V Jr, Okeke Claudia C Jan/Feb 2009 56-62 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Marks Zach Mar/Apr 2014 94-99 Buy
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A Jul/Aug 2004 251 Buy
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M May/Jun 2006 175-183 Buy